Advanced Biomedical Technologies
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Advanced Biomedical Technologies's past years’ income statements indicate that its last revenue has increased compared to the previous period by 58% to $270,991. The net income raised on -$515,485 and profit margin reached -190%. Total operating expenses were $401,764.

Profit Margin

Advanced Biomedical Technologies, Inc. (OTC:ABMT): Profit margin
2013 0 -890.34K
2014 0 -827.75K
2015 0 -862.85K
2016 0 -724.73K
2017 0 -691.6K
2018 0 -953.32K
2019 11.65K -1.25M -10787.8%
2020 123.58K -978.66K -791.88%
2021 171.19K -729.44K -426.1%
2022 270.99K -515.48K -190.22%

ABMT Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
270.99K171.19K123.58K11.65K000000
Cost of revenue
49.11K77.89K51.81K7.59K000000
Gross profit
221.87K93.29K71.77K4.06K000000
Operating exp.
Research and development
186.03K229.70K182.95K263.63K56.51K48.05K57.3K60.20K47.7K30.74K
Selling and marketing
0000000000
Total operating expenses
401.76K488.15K392.58K608.79K634.01K403.61K461.32K605.19K617.75K718.74K
Operating income
-179.88K-394.86K-320.81K-604.73K-634.01K-403.61K-461.32K-605.19K-617.75K-718.74K
Other income (expenses), net
-335.60K-334.58K-225.37K-344.08K-18.76K-287.98K-14.19K-257.66K-210.00K-11.23K
Income before tax
-515.48K-729.44K-672K-948.82K-953.32K-691.6K-724.73K-862.85K-827.75K-890.34K
Income tax expense
-1-4306.66K308.71K-18.73K-30.22K-14.13K241.45K201.47K160.43K
Net income
-515.48K-729.44K-978.66K-1.25M-953.32K-691.6K-724.73K-862.85K-827.75K-890.34K
Earnings per share
Basic EPS
-0.00-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01
Diluted EPS
-0.00-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source